Login
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
23 September 2026 at 19:31
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
